- Home
- SDGR vs EVV Comparison
SDGR vs EVV Comparison
Compare SDGR & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDGR | EVV |
|---|---|---|
| Founded | 1990 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | SDGR | EVV |
|---|---|---|
| Price | $18.76 | $9.99 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $26.25 | N/A |
| AVG Volume (30 Days) | ★ 850.2K | 323.7K |
| Earning Date | 02-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.66% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $256,951,000.00 | N/A |
| Revenue This Year | $23.69 | N/A |
| Revenue Next Year | $20.46 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 32.90 | N/A |
| 52 Week Low | $15.99 | $8.52 |
| 52 Week High | $28.47 | $10.07 |
Technical Indicators
Market Signals| Indicator | SDGR | EVV |
|---|---|---|
| Relative Strength Index (RSI) | 56.68 | 50.50 |
| Support Level | $17.50 | $9.90 |
| Resistance Level | $19.58 | $9.98 |
| Average True Range (ATR) | 0.70 | 0.05 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 68.95 | 82.86 |
Price Performance
Historical ComparisonAbout SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest
Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.